Literature DB >> 36068498

Impact of metal artifact reduction algorithm on gross tumor volume delineation in tonsillar cancer: reducing the interobserver variation.

Yoshiyuki Fukugawa1, Ryo Toya2, Tomohiko Matsuyama1, Takahiro Watakabe1, Yoshinobu Shimohigashi3, Yudai Kai3, Tadashi Matsumoto1, Natsuo Oya1.   

Abstract

BACKGROUND: Patients with tonsillar cancer (TC) often have dental fillings that can significantly degrade the quality of computed tomography (CT) simulator images due to metal artifacts. We evaluated whether the use of the metal artifact reduction (MAR) algorithm reduced the interobserver variation in delineating gross tumor volume (GTV) of TC.
METHODS: Eighteen patients with TC with dental fillings were enrolled in this study. Contrast-enhanced CT simulator images were reconstructed using the conventional (CTCONV) and MAR algorithm (CTMAR). Four board-certified radiation oncologists delineated the GTV of primary tumors using routine clinical data first on CTCONV image datasets (GTVCONV), followed by CTCONV and CTMAR fused image datasets (GTVMAR) at least 2 weeks apart. Intermodality differences in GTV values and Dice similarity coefficient (DSC) were compared using Wilcoxon's signed-rank test.
RESULTS: GTVMAR was significantly smaller than GTVCONV for three observers. The other observer showed no significant difference between GTVCONV and GTVMAR values. For all four observers, the mean GTVCONV and GTVMAR values were 14.0 (standard deviation [SD]: 7.4) cm3 and 12.1 (SD: 6.4) cm3, respectively, with the latter significantly lower than the former (p < 0.001). The mean DSC of GTVCONV and GTVMAR was 0.74 (SD: 0.10) and 0.77 (SD: 0.10), respectively, with the latter significantly higher than that of the former (p < 0.001).
CONCLUSIONS: The use of the MAR algorithm led to the delineation of smaller GTVs and reduced interobserver variations in delineating GTV of the primary tumors in patients with TC.
© 2022. The Author(s).

Entities:  

Keywords:  Gross tumor volume; Head and neck cancer; Metal artifact reduction; Oropharyngeal carcinoma; Radiotherapy; Radiotherapy planning

Mesh:

Year:  2022        PMID: 36068498      PMCID: PMC9450459          DOI: 10.1186/s12880-022-00889-0

Source DB:  PubMed          Journal:  BMC Med Imaging        ISSN: 1471-2342            Impact factor:   2.795


Background

Radiotherapy (RT) with or without chemotherapy is an organ preservation therapy commonly indicated for tonsillar cancer (TC) [1]. High-precision RT techniques such as intensity-modulated radiotherapy and volumetric-modulated arc therapy have become increasingly used for the treatment of TC [2]. As these RT techniques are characterized by highly conformal dose distributions, the treatment success highly depends on the accurate definition of gross tumor volume (GTV). Delineating GTV based on computed tomography (CT) simulator images is required for the RT planning process for TC. However, patients with TC often have dental fillings with metal artifacts in CT scans. Metal artifacts can significantly degrade the quality of simulation CT images, obscure visualization of the primary tumor, and therefore result in a large degree of interobserver variations in delineating GTV of primary tumors [3]. Recently, metal artifact reduction (MAR) algorithms have been increasingly used for CT imaging for the diagnosis and RT planning of head and neck cancer [4-7]. The commercially available software Smart MAR (GE Healthcare, Chicago, IL, USA) reduces photon starvation, beam hardening, and streak artifacts caused by high z metals in the body [5]. However, the usefulness of MAR algorithms in delineating the GTV of patients with TC is not fully discussed. Therefore, this study aimed to evaluate whether the use of MAR algorithms reduces interobserver variations in delineating the GTV of TC.

Methods

Patients

This retrospective study was approved by the institutional review board of our hospital. Between July 2019 and August 2021, 21 patients with pathologically confirmed tonsillar squamous cell carcinoma with dental fillings underwent pretreatment contrast-enhanced MR imaging within 4 weeks and contrast-enhanced [18F]-fluoro-2-deoxy-D-glucose (FDG)–positron emission tomography (PET)/CT within 6 weeks before RT planning contrast-enhanced CT imaging in our hospital [2]. Three patients were excluded due to the presence of superficial T1 lesions [3]. Finally, the study population consisted of 18 patients, comprising 12 males and 6 females (median age 57 [range 48–88] years). Patients were categorized according to the Union for International Cancer Control TNM staging system, 8th edition: 13 patients with T2, 4 with T3, and 1 with T4 tumors. The p16 status was positive in 15 and negative in 3 patients.

Imaging protocol

The pretreatment imaging protocols were described elsewhere [2, 8]. RT planning CT images with iodinated contrast media were acquired with a 16-row CT scanner (Discovery RT; GE Healthcare, Chicago, IL, USA). During CT scanning, patients were positioned supine with arms by their sides. A pillow and a thermoplastic mask dedicated to RT were used [9, 10]. A total of 80–100 ml of contrast media (Omnipaque 300, Daiichi-Sankyo, Tokyo, Japan) was injected at a 2 ml/s rate using a 22-G intravenous catheter placed in an antecubital vein. The CT scan was conducted 50–60 s after the initiation of contrast injection with helical mode, 120 kVp, Smart mA automatic exposure control (GE Healthcare, Chicago, IL, USA), 2.5-mm slice thickness, and 650-mm field of view (FOV). CT images were reconstructed using 500-mm FOV using the conventional (CTCONV) and Smart MAR algorithms (CTMAR). CTMAR removed metal artifacts based on the following steps: (1) identification of corrupted samples in the projection that corresponds to metallic objects, (2) generating inpainted data by replacing metal corrupted projections with the corrected data generated using the forward projection of the classified image, and (3) generating the final corrected projection by combining the original and inpainted projection data [11]. CTCONV and CTMAR images were transferred to the RT planning system (Pinnacle3 9.10; Philips Medical Systems, Fitchburg, MA, USA). Registration of images was performed with the RT planning system through hardware arrangement.

GTV definition

GTVs of primary tumors were delineated independently by four board-certified radiation oncologists with 5–18 years of experience. Observers were provided with routine clinical data (i.e., contrast-enhanced FDG/PET-CT and contrast-enhanced MR images and endoscopy videos) and asked to contour the GTV of each primary tumor on axial slices of CTCONV datasets. For each case, observers defined the GTV first on CTCONV image datasets (GTVCONV), followed by CTCONV and CTMAR fused image datasets (GTVMAR) at least 2 weeks apart to minimize memory bias and fatigue [9, 12]. When delineating GTVCONV, observers could not view CTMAR images. When delineating CTMAR, observers could view both CTCONV and CTMAR images. Observers could adjust the window level and width on their preferences for delineating GTV.

Evaluation of intermodality differences and observer variations

For each of 18 cases, 8 sets of GTVs were delineated: 4 (observers) × 2 (modalities). Analyses were performed based on three-dimensional volume. GTVCONV and GTVMAR values defined by 4 observers were calculated to evaluate intermodality (CTCONV images vs. CTCONV and CTMAR fused images) differences in GTVs. For geometric interobserver comparisons, the Dice similarity coefficient (DSC), which is used to measure the similarity between two samples, was calculated using the following equation:where A ∩ B is the volume of the intersection between two GTVs of A and B. The DSC ranged from 0 (no overlap) to 1 (perfect match) [10, 13, 14]. The DSC was calculated as the mean DSC of all possible pair combinations for both GTVCONV and GTVMAR [15].

Statistical analysis

Intermodality differences in GTV values and DSCs were compared using Wilcoxon’s signed-rank test. Statistical calculations were performed using the SPSS software version 25.0 (IBM, Armonk, NY, USA). Differences with p values of < 0.05 were considered statistically significant.

Results

The mean GTVCONV and GTVMAR values for four observers are shown in Table 1. GTVMAR was significantly smaller than GTVCONV for three observers. The other observer showed no significant difference between GTVCONV and GTVMAR values. For all four observers, the mean GTVCONV and GTVMAR values were 14.0 cm3 (standard deviation [SD]: 7.4) cm3 and 12.1 (SD: 6.4) cm3, respectively, indicating that GTVMAR was significantly smaller than GTVCONV (p < 0.001, Table 1).
Table 1

GTVCONV and GTVMAR values for four observers

ObserverGTVMean ± SD, cm3Range, cm3p Value
AGTVCONV15.7 ± 8.26.0–31.30.002
GTVMAR12.9 ± 6.93.7–30.4
BGTVCONV16.1 ± 7.64.4–29.50.006
GTVMAR13.3 ± 6.57.1–26.3
CGTVCONV11.4 ± 7.03.5–29.80.013
GTVMAR9.9 ± 5.63.3–21.1
DGTVCONV12.6 ± 6.32.7–25.10.433
GTVMAR12.3 ± 6.44.2–28.9
All observersGTVCONV14.0 ± 7.42.7–31.3 < 0.001
GTVMAR12.1 ± 6.43.3–30.4

GTV gross tumor volume, SD standard deviation, GTV gross tumor volume delineated based on conventional CT images, GTV gross tumor volume delineated based on the combination of conventional and metal artifact reduction CT images

GTVCONV and GTVMAR values for four observers GTV gross tumor volume, SD standard deviation, GTV gross tumor volume delineated based on conventional CT images, GTV gross tumor volume delineated based on the combination of conventional and metal artifact reduction CT images The mean DSCs of GTVCONV and GTVMAR were 0.74 (SD: 0.10) and 0.77 (SD: 0.10), respectively, indicating that the DSC of GTVMAR was significantly higher than that of GTVCONV (p < 0.001, Table 2). Figure 1 shows a representative patient with DSC of GTVMAR higher than that of GTVCONV.
Table 2

Dice similarity coefficient of GTVCONV and GTVMAR for each pair and all four observers

ObserverGTVCONV (Mean ± SD)RangeGTVMAR (Mean ± SD)Range
A and B0.71 ± 0.100.50–0.820.75 ± 0.100.49–0.84
A and C0.76 ± 0.100.53–0.890.80 ± 0.100.63–0.87
A and D0.75 ± 0.100.50–0.860.81 ± 0.100.48–0.89
B and C0.71 ± 0.100.52–0.840.73 ± 0.100.51–0.87
B and D0.75 ± 0.110.43–0.870.76 ± 0.110.47–0.87
C and D0.76 ± 0.100.51–0.860.80 ± 0.100.58–0.91
All observers0.74 ± 0.100.43–0.890.77 ± 0.100.47–0.91

GTV gross tumor volume delineated based on conventional CT images, SD standard deviation, GTV gross tumor volume delineated based on the combination of conventional and metal artifact reduction CT images

Fig. 1

Examples of gross tumor volume (GTV) in patients with tonsillar cancer. Each panel includes axial (left), sagittal (center), and coronal (right) images. A GTVs were delineated by four observers using conventional computed tomography (CT) images. The mean Dice similarity coefficient (DSC) was 0.80 with a mean GTV value of 23.7 cm3. B GTVs were delineated by four observers based on conventional and metal artifact reduction fused CT images. The mean DSC improved to 0.83 with a mean GTV value of 21.6 cm3 based on the combination of conventional and metal artifact reduction CT images

Dice similarity coefficient of GTVCONV and GTVMAR for each pair and all four observers GTV gross tumor volume delineated based on conventional CT images, SD standard deviation, GTV gross tumor volume delineated based on the combination of conventional and metal artifact reduction CT images Examples of gross tumor volume (GTV) in patients with tonsillar cancer. Each panel includes axial (left), sagittal (center), and coronal (right) images. A GTVs were delineated by four observers using conventional computed tomography (CT) images. The mean Dice similarity coefficient (DSC) was 0.80 with a mean GTV value of 23.7 cm3. B GTVs were delineated by four observers based on conventional and metal artifact reduction fused CT images. The mean DSC improved to 0.83 with a mean GTV value of 21.6 cm3 based on the combination of conventional and metal artifact reduction CT images

Discussion

RT for TC is associated with acute and late toxicities, including mucositis, dermatitis, taste dysfunction, xerostomia, and osteoradionecrosis. Therefore, an inappropriately large definition of target volumes may lead to deterioration in the quality of life of patients. Our study suggested that the addition of CTMAR to CTCONV images delineated smaller GTVs than CTCONV images alone in patients with TC. One possible reason is that observers unnecessarily included invisible areas due to metal artifacts in GTVCONV images to prevent marginal miss. Abelson et al. evaluated the effects of using the MAR technique on GTV delineation in 8 patients with TC [3]. Two radiation oncologists independently delineated the GTV of the primary tumor for each patient based on non-MAR CT (GTVnonMDT) and MAR CT (GTVMDT) images. GTVnonMDT and GTVMDT values of axial slices with metal artifacts were not significantly different. However, the number of patients was extremely low and may have thus yielded the difference between our results and theirs. The introduction of CTMAR images into RT planning may prevent unnecessary toxicities in patients with TC by reducing target volumes. Conversely, there is a possibility that smaller GTVs yielded using CTMAR images result in inappropriate dose distribution with unintended underdosing to the actual target volume. These benefits and risks should be considered when introducing CTMAR images into RT planning. Previous studies evaluated the ability of MAR algorithms to improve organ contouring in RT planning. Kohan et al. used CT images of 11 patients with metal artifacts in the head and neck regions [16]. Five independent observers with 0–6 years of experience including a medical student performed area measurements of selected normal organ structures, such as masseter muscles and tongues on non-MAR CT and MAR CT image slices with metallic objects and non-MAR CT slices without metallic objects as control. The intraclass correlation coefficient (ICC) was calculated to assess interobserver variations. For all observers, ICCs for non-MAR CT, MAR CT, and control non-MAR CT image slices were 0.903, 0.948, and 0.985 with outliers and 0.884, 0.971, and 0.989 without outliers, respectively. For experienced observers, ICCs for non-MAR CT, MAR CT, and control non-MAR CT image slices were 0.904, 0.979, and 0.976 with outliers and 0.934, 0.975, and 0.990 without outliers, respectively. They suggested the use of MAR algorithms greatly reduced the interobserver variation. Our study results suggested that the addition of CTMAR to CTCONV images reduced interobserver variations compared with CTCONV images alone in delineating GTV of primary tumors in patients with TC. Hansen et al. evaluated whether the introduction of MAR algorithms reduces interobserver variations in delineating GTV based on CT images of 11 patients with oropharyngeal cancer (OPC) [13]. Three experienced radiation oncologists and one experienced radiologist independently delineated the GTV of primary tumors (GTV-T) based on non-MAR and MAR CT images. The mean DSCs of GTV-T for non-MAR CT and MAR CT images were 0.60 (SD: 0.24) and 0.61 (SD: 0.20), respectively, showing no difference between the two modalities. The possible reason for the difference between our results and theirs are as follows: (1) the number of their patients was too small and (2) they included patients with OPC other than TC. Greater consistency in delineating GTV with MAR CT images should reduce the influence of potential variability during the RT planning process [17]. Our study has some limitations. First, this was a retrospective study with a relatively small number of patients, although it was larger than previous studies. Second, no pathologic gold standard has been established, which is unavoidable in this type of study. Third, the effects of adding MAR CT images based on dose distributions or treatment outcomes were not evaluated. Further prospective trials based on RT planning simulation using MAR CT images will be required to confirm the clinical benefits for patients with TC.

Conclusions

The use of MAR CT images in addition to conventional CT images led to the delineation of smaller GTVs and reduced interobserver variations in delineating GTV of primary tumors in patients with TC.
  16 in total

1.  The impact of orthopedic metal artifact reduction software on interreader variability when delineating areas of interest in the head and neck.

Authors:  Andres A Kohan; Christian Rubbert; Jose L Vercher-Conejero; Sasan Partovi; Andrew Sher; Jeffrey A Kolthammer; Patrick Wojtylak; Rodney J Ellis; James K O'Donnell
Journal:  Pract Radiat Oncol       Date:  2015-02-07

2.  Clinical relevance of metal artefact reduction in computed tomography (iMAR) in the pelvic and head and neck region: Multi-institutional contouring study of gross tumour volumes and organs at risk on clinical cases.

Authors:  Marius Hagen; Matthias Kretschmer; Florian Würschmidt; Tobias Gauer; Christian Giro; Elias Karsten; Jörn Lorenzen
Journal:  J Med Imaging Radiat Oncol       Date:  2019-07-02       Impact factor: 1.735

3.  Evaluation of two commercial CT metal artifact reduction algorithms for use in proton radiotherapy treatment planning in the head and neck area.

Authors:  Karin M Andersson; Christina Vallhagen Dahlgren; Johan Reizenstein; Yang Cao; Anders Ahnesjö; Per Thunberg
Journal:  Med Phys       Date:  2018-09-19       Impact factor: 4.071

4.  Intraobserver and interobserver variability in GTV delineation on FDG-PET-CT images of head and neck cancers.

Authors:  Stephen L Breen; Julia Publicover; Shiroma De Silva; Greg Pond; Kristy Brock; Brian O'Sullivan; Bernard Cummings; Laura Dawson; Anne Keller; John Kim; Jolie Ringash; Eugene Yu; Aaron Hendler; John Waldron
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-03-26       Impact factor: 7.038

5.  Image quality evaluation of in-treatment four-dimensional cone-beam computed tomography in volumetric-modulated arc therapy for stereotactic body radiation therapy.

Authors:  Yoshinobu Shimohigashi; Yasuhiro Doi; Yumiko Kouno; Yohei Yotsuji; Masato Maruyama; Yudai Kai; Ryo Toya
Journal:  Phys Med       Date:  2019-11-11       Impact factor: 2.685

Review 6.  Current and Novel Techniques for Metal Artifact Reduction at CT: Practical Guide for Radiologists.

Authors:  Masaki Katsura; Jiro Sato; Masaaki Akahane; Akira Kunimatsu; Osamu Abe
Journal:  Radiographics       Date:  2018 Mar-Apr       Impact factor: 5.333

7.  Contouring and dose calculation in head and neck cancer radiotherapy after reduction of metal artifacts in CT images.

Authors:  Christian Rønn Hansen; Rasmus Lübeck Christiansen; Ebbe Laugaard Lorenzen; Anders Smedegaard Bertelsen; Jon Thor Asmussen; Niels Gyldenkerne; Jesper Grau Eriksen; Jørgen Johansen; Carsten Brink
Journal:  Acta Oncol       Date:  2017-02-13       Impact factor: 4.089

8.  Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.

Authors:  Jaffer A Ajani; Thomas A D'Amico; David J Bentrem; Joseph Chao; David Cooke; Carlos Corvera; Prajnan Das; Peter C Enzinger; Thomas Enzler; Paul Fanta; Farhood Farjah; Hans Gerdes; Michael K Gibson; Steven Hochwald; Wayne L Hofstetter; David H Ilson; Rajesh N Keswani; Sunnie Kim; Lawrence R Kleinberg; Samuel J Klempner; Jill Lacy; Quan P Ly; Kristina A Matkowskyj; Michael McNamara; Mary F Mulcahy; Darryl Outlaw; Haeseong Park; Kyle A Perry; Jose Pimiento; George A Poultsides; Scott Reznik; Robert E Roses; Vivian E Strong; Stacey Su; Hanlin L Wang; Georgia Wiesner; Christopher G Willett; Danny Yakoub; Harry Yoon; Nicole McMillian; Lenora A Pluchino
Journal:  J Natl Compr Canc Netw       Date:  2022-02       Impact factor: 11.908

9.  Comparison of rigid and deformable image registration for nasopharyngeal carcinoma radiotherapy planning with diagnostic position PET/CT.

Authors:  Yudai Kai; Hidetaka Arimura; Ryo Toya; Tetsuo Saito; Tomohiko Matsuyama; Yoshiyuki Fukugawa; Shinya Shiraishi; Yoshinobu Shimohigashi; Masato Maruyama; Natsuo Oya
Journal:  Jpn J Radiol       Date:  2019-12-13       Impact factor: 2.374

10.  The application of metal artifact reduction methods on computed tomography scans for radiotherapy applications: A literature review.

Authors:  Sathyathas Puvanasunthararajah; Davide Fontanarosa; Marie-Luise Wille; Saskia M Camps
Journal:  J Appl Clin Med Phys       Date:  2021-05-03       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.